← CRS Congressional Research Service reports

Risk Evaluation and Mitigation Strategies (REMS) and Generic Drugs

IF · In Focus (2-page brief) · 2016-10-31 · IF10494

Report

CRS ID
IF10494
Series
In Focus (2-page brief)
Publication date
2016-10-31

Documents

PDF
https://www.everycrsreport.com/files/2016-10-31_IF10494_c26ef4d2a8241e01a887f8076710d20dbc3b8afb.pdf
HTML
https://www.everycrsreport.com/files/2016-10-31_IF10494_c26ef4d2a8241e01a887f8076710d20dbc3b8afb.html
Source
EveryCRSReport.com
Machine
JSON-LD · Markdown